Article ID Journal Published Year Pages File Type
6074185 Journal of Dermatological Science 2015 7 Pages PDF
Abstract

•Oxidation of phenols to ortho-quinones is followed by spectrophotometry and HPLC.•Leukoderma-inducing phenols are oxidized by mushroom tyrosinase to toxic ortho-quinones.•Phenolic tyrosinase inhibitors are not (or only slowly) oxidized by tyrosinase.•Tyrosinase inhibitors should be examined as substrates if they are phenolic compounds.

BackgroundTyrosinase is able to oxidize a great number of phenols and catechols to form ortho-quinones. Ortho-quinones are highly reactive compounds that exert cytotoxicity through binding with thiol enzymes and the production of reactive oxygen species. Certain phenolic (and catecholic) compounds are known to induce contact/occupational leukoderma through activation to ortho-quinones.ObjectiveWe report a convenient screening method to follow the oxidation of those leukoderma-inducing phenols by mushroom tyrosinase.MethodsOxidation of phenolic compounds by mushroom tyrosinase was followed periodically by UV-vis spectrophotometry. The production of ortho-quinones were confirmed by their absorptions around 400-420 nm. HPLC analysis after reduction with NaBH4 detected the corresponding catechols.ResultsLeukoderma-inducing phenols, rhododendrol, raspberry ketone, 4-methoxyphenol, 4-benzyloxyphenol, 4-tert-butylphenol, and 4-tert-butylcatechol, were readily oxidized by mushroom tyrosinase to form ortho-quinones. On the other hand, phenolic skin whitening tyrosinase inhibitors, ellagic acid, 4-n-butylresorcinol, potassium 4-methoxysalicylate, and 2,2′-dihydroxy-5,5′-di-n-propylbiphenyl, were not oxidized by mushroom tyrosinase, while arbutin was only slowly oxidized.ConclusionThis study has provided a convenient screening method to differentiate phenolic skin whitening tyrosinase inhibitors from leukoderma-inducing phenols. A common chemical feature of the latter group of compounds is that they are readily oxidized by tyrosinase to form reactive ortho-quinone species. The present results point out the necessity that tyrosinase inhibitors should also be examined as substrates if they are phenolic compounds.

Related Topics
Health Sciences Medicine and Dentistry Dermatology
Authors
, ,